Sanyou Bio’s Impressive Growth Journey in China’s Biopharmaceutical Landscape

In the realm of China’s biopharmaceutical sector, the past decade has been pivotal for Sanyou Bio, witnessing its remarkable evolution from inception to industry leadership. Launched by Lang Guojun in 2015, Sanyou Bio transitioned from a startup with modest facilities to a prominent player boasting cutting-edge technology. Today, the company stands as a frontrunner with its Intelligent Super-Trillion Antibody Library, state-of-the-art R&D platforms, and extensive operational infrastructure. A decade of strategic focus has propelled Sanyou Bio’s newest milestone – the inauguration of its Innovation Hub for Original Drug Discovery. This initiative integrates global R&D resources with its antibody library to…